Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03327623 · ClinicalTrials.gov registry record
Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 290
- Enrollment target
NCT03327623: Completed study, sponsored by Mayo Clinic.
NCT03327623 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 290 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03327623 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 290 participants
- Enrollment target
Study Summary
The investigators are trying to find out how common sleep apnea is in hypertrophic cardiomyopathy. The purpose of this study is to see if sleep apnea is common in hypertrophic cardiomyopathy and if its presence is associated with changes in the functioning of the body. The investigators want to determine if sleep apnea is associated with electrical disorders of the heart in patients with hypertrophic cardiomyopathy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2017-11-13 |
| Est. Completion | 2024-06-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03327623
The ClinicalTrials.gov registry entry for NCT03327623 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03327623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03327623 about?
NCT03327623 is a clinical study titled "Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)". The investigators are trying to find out how common sleep apnea is in hypertrophic cardiomyopathy. The purpose of this study is to see if sleep apnea is common in hypertrophic cardiomyopathy and if its presence is associated with changes in the functioning of the body. The investigators want to dete...
What is the current status of trial NCT03327623?
This trial is currently completed. The enrollment target is 290 participants. The study started on 2017-11-13. Estimated completion is 2024-06-21.
Who is sponsoring clinical trial NCT03327623?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.